RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Creo Medical Group Stock

Creo Medical Group Net Income 2024

Creo Medical Group Net Income

-13.71 M GBP

Ticker

CREO.L

ISIN

GB00BZ1BLL44

WKN

A2DH40

In 2024, Creo Medical Group's profit amounted to -13.71 M GBP, a -36.82% increase from the -21.7 M GBP profit recorded in the previous year.

The Creo Medical Group Net Income history

YEARNET INCOME (undefined GBP)
2029e-
2028e-
2027e7.05
2026e5.18
2025e-3.01
2024e-13.71
2023-21.7
2022-26.94
2021-24.6
2020-20.32
2019-15.91
2018-14.81
2017-7.77
2016-1.61
2015-3.33
2014-2.38
2013-1.7

Creo Medical Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Creo Medical Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Creo Medical Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Creo Medical Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Creo Medical Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Creo Medical Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Creo Medical Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Creo Medical Group’s growth potential.

Creo Medical Group Revenue, EBIT and net profit per share

DateCreo Medical Group RevenueCreo Medical Group EBITCreo Medical Group Net Income
2029e152.61 M undefined0 undefined0 undefined
2028e127.91 M undefined0 undefined0 undefined
2027e96.82 M undefined14.89 M undefined7.05 M undefined
2026e70.7 M undefined4.04 M undefined5.18 M undefined
2025e54.11 M undefined-4.37 M undefined-3.01 M undefined
2024e39.96 M undefined-15.79 M undefined-13.71 M undefined
202330.8 M undefined-24.8 M undefined-21.7 M undefined
202227.17 M undefined-30.76 M undefined-26.94 M undefined
202125.16 M undefined-29.91 M undefined-24.6 M undefined
20209.43 M undefined-23.48 M undefined-20.32 M undefined
201913,470 undefined-18.88 M undefined-15.91 M undefined
20180 undefined-17.66 M undefined-14.81 M undefined
20170 undefined-8.9 M undefined-7.77 M undefined
20160 undefined-1.87 M undefined-1.61 M undefined
20150 undefined-3.8 M undefined-3.33 M undefined
20140 undefined-2.88 M undefined-2.38 M undefined
20130 undefined-1.95 M undefined-1.7 M undefined

Creo Medical Group stock margins

The Creo Medical Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Creo Medical Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Creo Medical Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Creo Medical Group's sales revenue. A higher gross margin percentage indicates that the Creo Medical Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Creo Medical Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Creo Medical Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Creo Medical Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Creo Medical Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Creo Medical Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Creo Medical Group Margin History

Creo Medical Group Gross marginCreo Medical Group Profit marginCreo Medical Group EBIT marginCreo Medical Group Profit margin
2029e49.68 %0 %0 %
2028e49.68 %0 %0 %
2027e49.68 %15.38 %7.28 %
2026e49.68 %5.71 %7.33 %
2025e49.68 %-8.08 %-5.57 %
2024e49.68 %-39.51 %-34.31 %
202349.68 %-80.52 %-70.45 %
202248.3 %-113.2 %-99.14 %
202146.04 %-118.86 %-97.75 %
202042.79 %-249.07 %-215.46 %
201936.75 %-140,129.03 %-118,122.86 %
201849.68 %0 %0 %
201749.68 %0 %0 %
201649.68 %0 %0 %
201549.68 %0 %0 %
201449.68 %0 %0 %
201349.68 %0 %0 %

Creo Medical Group Aktienanalyse

What does Creo Medical Group do?

Creo Medical Group PLC is a British medical technology company that was founded in 2003 and is based in Chepstow, Wales. The company specializes in the development and marketing of innovative medical devices. Creo Medical aims to improve the lives of healthcare professionals and patients by providing them with state-of-the-art technology. The company's business model focuses on research, development, and sales of innovative medical devices. Their goal is to provide doctors with the most advanced technology to facilitate their work. Creo Medical offers a wide range of devices for endoscopic surgery. They follow an asset-light model, outsourcing production to save costs and increase efficiency. Creo Medical was founded in 2003 by a team of professionals consisting of doctors and engineers. Their objective was to promote the development of cutting-edge technology for the medical industry and improve the treatment of patients worldwide. The company quickly gained momentum and received its first patent in 2014. Their product range includes endoscopes and electrosurgical devices for endoscopic surgery. Endoscopes are used to visualize the internal surfaces of the body through a flexible tube inserted through a small incision. This type of technology is used in surgery, particularly in gastrointestinal and gynecological areas. Electrosurgical devices are used in heart surgery and to prevent bleeding during operations. Creo Medical operates in various sectors where their products are utilized: 1. Gastroenterology: focusing on the diagnosis and treatment of digestive tract diseases. 2. Laparoscopic surgery: a surgical technique that uses a few small incisions to introduce surgical instruments into the body. 3. Gynecology: dealing with the diagnosis and treatment of diseases in the female reproductive system. 4. Urology: involving the treatment of diseases in the urinary tract and male reproductive system. Creo Medical serves multiple markets and recently announced the acquisition of Albyn Medical, a leading British manufacturer and distributor of medical devices. The company reported a 68% increase in revenue to £8.8 million in 2020, attributing the growth to growing demand for laparoscopic and gastroenterological products. Creo Medical's stock was listed on London's AIM in 2018. In conclusion, Creo Medical is a British medical technology company specializing in the development, manufacturing, and marketing of medical devices used in various medical fields. Their advanced technologies contribute to breakthroughs in surgery, making procedures more precise and gentle. Creo Medical has become a significant player in the British and international medical industry and will continue to play an important role in this sector. Creo Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Creo Medical Group's Profit Margins

The profit margins of Creo Medical Group represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Creo Medical Group's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Creo Medical Group's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Creo Medical Group's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Creo Medical Group’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Creo Medical Group stock

How much profit has Creo Medical Group made this year?

Creo Medical Group has made -13.71 M GBP this year.

How has the profit developed compared to last year?

The profit has increased by -36.82% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Creo Medical Group publish its earnings?

Creo Medical Group publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Creo Medical Group?

The profits of Creo Medical Group are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Creo Medical Group?

You can learn more about the earnings of Creo Medical Group by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Creo Medical Group pay?

Over the past 12 months, Creo Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Creo Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Creo Medical Group?

The current dividend yield of Creo Medical Group is .

When does Creo Medical Group pay dividends?

Creo Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Creo Medical Group?

Creo Medical Group paid dividends every year for the past 0 years.

What is the dividend of Creo Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Creo Medical Group located?

Creo Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Creo Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Creo Medical Group from 7/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Creo Medical Group pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Creo Medical Group in the year 2023?

In the year 2023, Creo Medical Group distributed 0 GBP as dividends.

In which currency does Creo Medical Group pay out the dividend?

The dividends of Creo Medical Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Creo Medical Group

Our stock analysis for Creo Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Creo Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.